Tag: drug patent strategies

Explore how drug makers use product hopping and REMS abuse to block generic substitution, violating antitrust laws. Learn about key cases like NY v. Actavis and the billions in costs to consumers.

Recent-posts

Predicting Generic Entry: How to Forecast When Your Drug Will Face Generic Competition

Jan, 13 2026

Head Injury While on Blood Thinners: When to Get Imaging

Mar, 20 2026

What to Do If a Child Swallows the Wrong Medication: Immediate Steps to Save a Life

Jan, 19 2026

Olmesartan/Amlodipine Interactions: Essential Guide for Patients and Clinicians

Oct, 23 2025

MedlinePlus Drug Information: A Guide to Safe Medication Use

Apr, 16 2026